AstraZeneca says antibody drug works to prevent Covid-19 in longer-term studies

LONDON,― AstraZeneca said today its Covid-19 antibody drug was 83 per cent effective in cutting the risk of people contracting symptomatic illness in a six-month follow-up study, cementing the drugmaker's lead in developing preventative…